Torbjörn Mattias Koivisto
Director/Board Member at XSPRAY PHARMA AB
Net worth: 23 624 $ as of 2024-03-30
Network origin in Torbjörn Mattias Koivisto first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 16 | |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021.
4
| Holding Company | Biotechnology | 4 |
Kibacq AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Torbjörn Mattias Koivisto via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Chairman | |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Chief Executive Officer | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer | |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Director/Board Member | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
Cereal Base Ceba AB
 Cereal Base Ceba AB Miscellaneous Commercial ServicesCommercial Services Part of Oatly Group AB, Cereal Base Ceba AB is a Swedish company that researches, develops, markets, and sells oat-based non-dairy products. The private company is based in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Chalmers University of Technology | College/University | Director/Board Member Graduate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Stockholm | College/University | Doctorate Degree Graduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
CEBA AB
 CEBA AB Food: Major DiversifiedConsumer Non-Durables CEBA AB supplies functional food and men's and women's apparel. It also produces a non-dairy complete fluid food. The company's Oatly product is based on an oat emulsion, which consits of proteins, carbohydrates, lipids, and suitable fiber content. CEBA is located in Orebro, Sweden. | Food: Major Diversified | Chairman Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal | |
| University of Lund | College/University | Corporate Officer/Principal Undergraduate Degree | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Advantice Health LLC (New Jersey)
 Advantice Health LLC (New Jersey) Medical DistributorsDistribution Services Advantice Health LLC manufactures and supplies therapeutic medicines and personal products. It is engaged in the marketing, sale and distribution of over-the-counter (OTC) medicines to drug stores, food stores, mass merchandisers, health professionals and international markets. It is best known for podiatrist recommended Kerasal One-Step Exfoliating Moisturizer Therapy. The company was founded in 2004 and is headquartered in Cedar Knolls, NJ. | Medical Distributors | Director/Board Member Chief Operating Officer | |
Unimedic AB
 Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GHP SPECIALTY CARE AB (PUBL) | Medical/Nursing Services | Chairman Corporate Officer/Principal | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chairman Corporate Officer/Principal | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Oatly AB
 Oatly AB Food: Major DiversifiedConsumer Non-Durables Oatly AB produces and markets oat drinks and ice creams. Its products include organic oat drink chilled, chocolate oat drink, apple pear oat drink, vanilla organic oat drink kid’s edition, iMat fraiche and vanilla sauce. The firm provides its products for use in various recipes, including breakfast and starters, main courses, desserts, baking products, drinks, and sauces and dressings. The company was founded in 1994 by Rickard Öste and is headquartered in Malmo, Sweden. | Food: Major Diversified | Chairman Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SWEDENCARE AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| SEDANA MEDICAL AB | Medical Specialties | Chairman Chief Executive Officer | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Cinclus Pharma AG
 Cinclus Pharma AG BiotechnologyHealth Technology Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca. | Biotechnology | Director/Board Member Director/Board Member | |
| Medivir Personal AB | Director/Board Member Director/Board Member | ||
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The private company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Glycovisc BioTech AB | Director/Board Member Director/Board Member | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Swedencare AB (publ)
 Swedencare AB (publ) Agricultural Commodities/MillingProcess Industries Swedencare AB (publ) offers a wide range of premium pet health products for dogs, cats, and horses. The private company is based in Malmö, Sweden. The Swedish company provides safe, natural, and easy-to-use dental care products such as Crunchy Dental Bites, Chews, Bones, Powder, and more. It was founded in 1993, and the CEO is Lars Håkan Lagerberg. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 47 |
| United Kingdom | 2 |
| Denmark | 2 |
| United States | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Consumer Non-Durables | 4 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 291 |
| Chairman | 113 |
| Corporate Officer/Principal | 98 |
| Independent Dir/Board Member | 62 |
| Chief Executive Officer | 49 |
Most connected contacts
- Stock Market
- Insiders
- Torbjörn Mattias Koivisto
- Company connections
